Abstract
Fournier’s gangrene (FG) is a rare, rapidly progressive, fulminant form of necrotizing fasciitis of the genital, perianal and perineal regions. Several factors have been reported to contribute to the clinical outcomes. The primary aims of this study were to examine the clinical features of patients with FG and evaluate the predictivity of the Fournier’s Gangrene Severity Index (FGSI) score on the outcomes. We carried out a collective retrospective chart review of patients diagnosed and treated for FG in three reference centers between January 1995 and July 2007. Seventy-two patients with FG with were included to the study. Data were collected on medical history, symptoms, physical examination findings, admission and final laboratory tests, timing and extent of surgical debridement and antibiotic therapy. Perianal and perirectal abscess, scrotal abscess and urethral stenosis were the leading etiological factors. Diabetes mellitus was the predominant risk factor. Etiological factors and risk factors did not significantly contribute to survival or mortality, and duration of the symptoms was significantly longer in the non-survivor's group (P < 0.05). The FGSI scores were higher in the non-survivor's group. Regression analysis showed a FGSIS score of 10.5 as the cut-off to the outcome. Based on these results, we conclude that a patient’s metabolic status and the extent of disease at presentation are the most important factors determining the prognosis of FG. The FGSI score may be considered as an objective and simple tool to predict the outcome in the patient with FG and should be used in further studies of FG patient series for comparison purposes.
Similar content being viewed by others
References
Corman JM, Moody JA, Aranson WL (1999) Fournier’s gangrene in a modern surgical setting: improved survival with aggressive management. Br J Urol Int 84:85–88
Yanar H, Taviloglu K, Ertekin C, Guloglu R, Zorba U, Cabioglu N, Baspinar I (2006) Fournier’s gangrene. Risk factors and strategies for management. World J Surg 30:1750–1754
Fowler JE (1996) Necrotizing fasciitis of the male genitalia. Monog Urol 17:1–12
Clayton MD, Fowler JE Jr, Sharifi R, Pearl RK (1990) Causes, presentation and survival of fifty-seven patients with necrotizing fascitis of the male genitalia. Surg Gynecol Obstet 170:49–55
Laucks SS (1994) Fournier’s gangrene. Surg Clin North Am 74:1339–1352
Jeong HJ (2004) Fournier’s gangrene associated with sparganosis in the scrotum. Urology 63:176–177
Laor E, Palmer LS, Tolia BM, Reid RE, Winter HI (1995) Outcome prediction in patients with Fournier’s gangrene. J Urol 154:189–192
Stephens BJ, Lathrop JC, Rice WT, Gruenberg JC (1993) Fournier’s gangrene: historic (1764–1978) versus contemporary (1976–1988) differences in etiology and clinical importance. Am Surg 7:149–154
Dietrich NA, Mson JH (1983) Fournier’s gangrene: a general surgery problem. World J Surg 7:288–294
Safioleas M, Stamatakos M, Mouzopoulos G, Diab A, Kontzoglu K, Papachristodoulou A (2006) Fournier’s gangrene: exists and is still lethal. Int Urol Nephrol 30:1750–1754
Enriquez JM, Moreno S, Devasa M, Morales V, Platas A, Vicente E (1987) Fournier’s syndrome of urogenital and anorectal origin. A retrospective and comparative study. Dis Colon Rectum 30:33–37
Dahm P, Roland FH, Vaslef SN, Moon RE, Price DT, Georgiade GS, Vieweg J (2000) Outcome analysis in patients with primary necrotizing fasciitis of the male genitalia. Urology 56:31–35
Korkut M, Icoz G, Dayangac M, Akgun E, Yeniay L, Erdogan O, Cal C (2003) Outcome analysis in patients with Fournier’s gangrene: report of 45 cases. Dis Colon Rectum 46:649–652
Asfar SK, Baraka A, Juma T, Ma’Rafie A, Aladeen T, al Sayer H (1991) Necrotizing fasit. Br J Surg 78:838–840
Moorthy K, Rao PP, Supe AN (2000) Necrotizing perineal infection: a fatal outcome of ischiorectal fossa abscesses. J R Coll Surg Edinb 45:281–284
Hejase MJ, Simonin JE, Birhle R, Coogan CL (1996) Genital Fournier’s gangrene: experience with 38 patients. Urology 47:734–739
Eke N (2000) Fournier’s gangrene: a review of 1726 cases. Br J Surg 87:718–728
Capelli-Schellpfeffer M, Gerber GS (1999) The use of hyperbaric oxygen in urology. J Urol 162:647–654
Pizzorno R, Bonini F, Donelli A, Stubinski R, Medica M, Carmignani G (1997) Hyperbaric oxygen therapy in the treatment of Fournier’s disease in 11 male patients. J Urol 158:837–840
Hollabaugh RS Jr, Dmochowski RR, Hickerson WL, Cox CE (1998) Fournier’s gangrene: therapeutic impact of hyperbaric oxygen. Plast Reconstr Surg 101:94–100
Paty R, Smith AD (1992) Gangrene and Fournier’s gangrene. Urol Clin North Am 19:149–162
Cohen MS (1986) Fournier’s gangrene. Am Urol Assoc Update Ser 5:1–6
Efem SE, Udoh KT, Iwara CI (1992) The antimicrobial spectrum of honey and its clinical significance. Infection 20:227–229
Wahdan HA (1998) Causes of the antimicrobial activity of honey. Infection 26:26–31
Knaus WA, Zimmerman JE, Wagner DP, Draper EA, Lawrence DE (1981) APACHE-acute physiology and chronic health evaluation: a physiologically based classification system. Crit Care Med 9:591–597
Broughan TA, Hermann RE, Hardesty IJ, Paranandi L (1994) Fascial closure in the management of infected pancreatic necrosis. Am Surg 60:309–312
Hwang TL, Huang SL, Chen MF (1993) The use of indirect calorimetry in critically ill patients—the relationship of measured energy expenditure to injury severity score, septic severity score, and APACHE II score. J Trauma 34:247–251
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kabay, S., Yucel, M., Yaylak, F. et al. The clinical features of Fournier’s gangrene and the predictivity of the Fournier’s Gangrene Severity Index on the outcomes. Int Urol Nephrol 40, 997–1004 (2008). https://doi.org/10.1007/s11255-008-9401-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-008-9401-4